Difference between revisions of "Perseus LLC"
Line 1: | Line 1: | ||
− | '''Perseus LLC''' (''Perseus'') is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from [[venture capital]] financings to leveraged | + | '''[http://207.19.194.179/intro.htm Perseus LLC]''' (''Perseus'') is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from [[venture capital]] financings to [[leveraged buyout]]s and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."[http://207.19.194.179/intro.htm] |
Perseus and its affiliates manage five investment funds: | Perseus and its affiliates manage five investment funds: | ||
Line 9: | Line 9: | ||
*Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund") | *Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund") | ||
− | == | + | == Leadership == |
*[[Frank H. Pearl]], Chairman and Chief Executive Officer | *[[Frank H. Pearl]], Chairman and Chief Executive Officer | ||
− | *[[Richard Charles Albert | + | *[[Richard Charles Albert Holbrooke]], Vice Chairman |
*[[James A. Johnson]], Vice Chairman | *[[James A. Johnson]], Vice Chairman | ||
+ | |||
+ | |||
+ | *[http://207.19.194.179/bios.htm#top Other Perseus Biographies] | ||
*[[Lewis A. Lee Sachs]], Vice Chairman | *[[Lewis A. Lee Sachs]], Vice Chairman | ||
*[[John T. Schwieters]], Vice Chairman | *[[John T. Schwieters]], Vice Chairman | ||
Line 20: | Line 23: | ||
*[[William B. Ford]], Managing Director | *[[William B. Ford]], Managing Director | ||
*[[John C. Fox]], Managing Director | *[[John C. Fox]], Managing Director | ||
− | |||
*[[Curtis A. Glovier]], Managing Director | *[[Curtis A. Glovier]], Managing Director | ||
*[[Thomas G. Labrecque, Jr.]], Managing Director | *[[Thomas G. Labrecque, Jr.]], Managing Director | ||
*[[Ray E. Newton III]], Managing Director | *[[Ray E. Newton III]], Managing Director | ||
*[[Charles C. Moore]], Managing Director | *[[Charles C. Moore]], Managing Director | ||
+ | *[[Rajeev Garside]], Vice President | ||
*[[Lisa M. Schule]], Vice President | *[[Lisa M. Schule]], Vice President | ||
*[[Richard J. Shin]], Vice President | *[[Richard J. Shin]], Vice President | ||
Line 31: | Line 34: | ||
*[[Brian W. Farr]], Controller | *[[Brian W. Farr]], Controller | ||
− | ==Contact | + | == Contact == |
− | + | ||
− | + | 2099 Pennsylvania Avenue, N.W., 9th Floor<br> | |
− | + | Washington, D.C. 20006<br> | |
− | + | Tel. 202.452.0101<br> | |
− | + | Fax 202.429.0588<br> | |
+ | |||
+ | 888 Seventh Avenue, 29th Floor<br> | ||
+ | New York, NY 10106<br> | ||
+ | Tel. 212.397.3680<br> | ||
+ | Fax 212.245.1852<br> | ||
− | + | information@perseusllc.com<br> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | == | + | -------- |
+ | == Other Related SourceWatch Resources == | ||
+ | |||
*[[banking]] | *[[banking]] | ||
− | == External | + | == External Links == |
− | |||
− |
Latest revision as of 20:19, 19 July 2016
Perseus LLC (Perseus) is a "merchant bank and private equity fund management company with offices in Washington, D.C. and New York City. Since its inception in 1994, Perseus has invested in a broad range of transactions from venture capital financings to leveraged buyouts and debt market investments. Perseus generally invests in companies in which it can participate in the company's strategic planning, operations and development and thereby add significant value to the investment. In particular, Perseus invests in companies that have the strategic characteristics described more fully below, i.e., proprietary intellectual property, powerful brands, unique content or a highly skilled work force."[1]
Perseus and its affiliates manage five investment funds:
- Perseus 1996
- Perseus Capital, L.L.C. ("Perseus Capital")
- Perseus 2000, L.L.C. ("Perseus 2000")
- Perseus Acquisition/Recapitalization Fund, L.L.C. (the "Acquisition/Recap Fund")
- Perseus-Soros BioPharmaceutical Fund, L.P. (the "BioPharmaceutical Fund")
Leadership
- Frank H. Pearl, Chairman and Chief Executive Officer
- Richard Charles Albert Holbrooke, Vice Chairman
- James A. Johnson, Vice Chairman
- Other Perseus Biographies
- Lewis A. Lee Sachs, Vice Chairman
- John T. Schwieters, Vice Chairman
- Kenneth M. Socha, Senior Managing Director
- Philip J. Deutch, Managing Director
- William B. Ford, Managing Director
- John C. Fox, Managing Director
- Curtis A. Glovier, Managing Director
- Thomas G. Labrecque, Jr., Managing Director
- Ray E. Newton III, Managing Director
- Charles C. Moore, Managing Director
- Rajeev Garside, Vice President
- Lisa M. Schule, Vice President
- Richard J. Shin, Vice President
- Richard M. Fruzzetti, Associate
- Rodd J. Macklin, Chief Financial Officer
- Brian W. Farr, Controller
Contact
2099 Pennsylvania Avenue, N.W., 9th Floor
Washington, D.C. 20006
Tel. 202.452.0101
Fax 202.429.0588
888 Seventh Avenue, 29th Floor
New York, NY 10106
Tel. 212.397.3680
Fax 212.245.1852
information@perseusllc.com